Vitreoretinal degeneration
MONDO:0020248Also known as: degenerative vitreoretinopathy
58 clinical trials for this condition and its sub-types, 0 tagged with Vitreoretinal degeneration itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Vitreoretinal degeneration
-
Exudative vitreoretinopathy 1 trial · 35 incl. sub-types
9 sub-types
- FZD4-related exudative vitreoretinopathy 0 trials · 33 incl. sub-types Sub-types →
- Dyneinopathy 0 trials · 1 incl. sub-types Sub-types →
- LRP5-related exudative vitreoretinopathy 0 trials Sub-types →
- TSPAN12-related exudative vitreoretinopathy 0 trials Sub-types →
- Exudative vitreoretinopathy 2, X-linked 0 trials
- Exudative vitreoretinopathy 3 0 trials
- Exudative vitreoretinopathy 6 0 trials
- Exudative vitreoretinopathy 7 0 trials
- Exudative vitreoretinopathy 8 0 trials
-
X-linked retinoschisis 4 trials
-
Stickler syndrome 2 trials · 4 incl. sub-types
5 sub-types
- Stickler syndrome type 1 3 trials Sub-types →
- Stickler syndrome type 2 2 trials
- Stickler syndrome, type 4 0 trials
- Stickler syndrome, type 5 0 trials
- Stickler syndrome, type 6 0 trials
-
Enhanced S-cone syndrome 2 trials
2 sub-types
- Goldmann-Favre syndrome 1 trial
- Enhanced S-cone syndrome 2 0 trials
-
Wagner disease 1 trial
-
1 sub-type
-
CAPN5-related vitreoretinopathy 0 trials
-
Knobloch syndrome 0 trials
2 sub-types
- Knobloch syndrome 1 0 trials
- Knobloch syndrome 2 0 trials
-
Snowflake vitreoretinal degeneration 0 trials
Most studied deeper sub-types
-
Tiny doses of avastin tested against laser for preemie eye disease
Disease control Stopped earlyThis study tested a low dose of the drug bevacizumab (Avastin) against standard laser treatment for retinopathy of prematurity, an eye disease that can blind premature infants. Sixteen babies with severe disease were enrolled. The goal was to see if the drug could control the dis…
Phase 3 • Sponsor: Jaeb Center for Health Research • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
VR headsets tested as a possible treatment for blindness
Disease control Stopped earlyThis study tested whether using a virtual reality headset for one-hour sessions could help regenerate damaged optic nerves and improve vision in people with glaucoma or other retinal diseases. The idea came from promising results in rodents. However, the trial was terminated earl…
Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC